Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects-the evidence-based 3PM proposition to mitigate individual risks.
EPMA J
; 12(3): 325-347, 2021 Sep.
Article
em En
| MEDLINE
| ID: mdl-34367380
ARDS; Anti-inflammation, Antibacterial; Antiviral, COVID-19; Cancer, Chronic diseases; Coumarins; Cytokine storm; Disease management; Flavonoids; Health economy; Health policy; Immunity; Inflammation; Lung damage; Phenolic acids; Phenolic compounds; Phytochemicals; Predictive preventive personalized medicine (3PM/PPPM); Risk assessment; Signaling pathways; Stilbenoids; Therapy efficacy
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article